– Bringing Unprecedented Medical Expertise by Strengthening Partnerships with Pharmaceutical Corporations in Japan and U.S. to Construct Medical Information Platform –
TOKYO and SINGAPORE, Aug. 22, 2022 /PRNewswire/ — Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare information for everybody,” introduced that it has raised $26.2 million (*1) within the 1st spherical of Sequence C funding. New buyers within the spherical embrace Norinchukin Capital Co., Ltd., NVenture Capital Restricted (wholly owned subsidiary of NEC Capital Options Restricted), The Dai-ichi Life Insurance coverage Firm, Restricted, and Egg FORWARD, Inc., whereas present buyers embrace SUZUKEN CO., LTD. Up to now, Ubie has raised $59.8 million (*2).
Ubie is among the few startups on the planet with a medical knowledge platform that has direct contact with each sufferers and medical establishments. Ubie affords two providers that concentrate on the “medical questionnaire” as a gateway to healthcare, utilizing AI as its core expertise.
The “AI-powered symptom checker,” offered for sufferers, asks round 20 questions on their signs to find associated illnesses and supply extra detailed actionable well being data. Since its launch, it has been trusted by 5 million month-to-month customers worldwide, together with in Japan and the U.S.
Ubie affords “AI-powered affected person consumption,” a service that streamlines the medical interview course of for medical establishments. This service relies on a database of roughly 50,000 medical articles from all over the world, created by greater than 50 energetic physicians. The service has been launched to greater than 1,000 medical establishments worldwide and continues to enhance the operational effectivity of those establishments.
Ubie will purpose to convey a brand new medical expertise to Japan and the U.S. by connecting sufferers, medical establishments, and pharmaceutical firms by way of the medical knowledge platform it’s constructing to unravel the next medical points;
– guaranteeing that sufferers go to the appropriate medical establishment on the proper time,
– guaranteeing that physicians can entry related, up-to-date data from the huge quantity of the newest data on illnesses and uncommon illnesses that aren’t their specialty, and,
– guaranteeing that pharmaceutical firms proceed to offer sufferers with the suitable data and scientific findings associated to their circumstances.
Sequence C funding will probably be used to gasoline enterprise development in Japan and the U.S. to construct a medical knowledge platform that connects sufferers, medical establishments, and pharmaceutical firms.
Ubie Co-founder and CEO Yoshinori Abe, MD, mentioned: “Not solely in Japan, but additionally in different international locations, the present healthcare system is affected by numerous losses as a result of fragmentation of data held by sufferers, medical establishments, and pharmaceutical firms. This fundraising goals to speed up collaboration with pharmaceutical firms and create an unprecedented consumer-centered medical expertise using Ubie’s knowledge platform. Ubie already has enterprise with greater than 20 main pharmaceutical firms in Japan and different international locations, and this brings Ubie nearer to realizing its mission ‘To develop a healthcare information for everybody,’ each in Japan and the U.S.”
(*1) $26.2 million = JPY 3.5 billion (as of August 12, 2022)
(*2) $59.8 million = JPY 7.98 billion (similar as above)
Ubie is a Japanese health-tech startup based by a medical physician and an engineer in 2017. Utilizing AI as its core expertise, the corporate develops and supplies an AI-powered affected person questionnaire that guides sufferers from signs to applicable medical care and improves operational effectivity within the medical discipline. Ubie is selling the creation of a society during which anybody can entry medical care that fits them finest.
For extra data, please go to: http://firm.ubiehealth.com
AI-powered symptom checker: https://ubiehealth.com
(Japanese model: https://ubie.app/ )
SOURCE Ubie, Inc.